ACTG Publications

TitleAuthorsDateJournalIssueVolume
Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164.Sax, Paul E ; Sloan, Caroline E ; Schackman, Bruce R ; Grant, Philip M ; Rong, Jian ; Zolopa, Andrew R ; Powderly, William ; Losina, Elena ; Freedberg, Kenneth A ; Cepac US And Actg A5164 Investigators2010 Sep-OctHIV Clin Trials511
Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.Zolopa, Andrew ; Andersen, Janet ; Powderly, William ; Sanchez, Alejandro ; Sanne, Ian ; Suckow, Carol ; Hogg, Evelyn ; Komarow, Lauren2009PLoS One54
Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b).Andrade, Adriana ; Guedj, Jeremie ; Rosenkranz, Susan L ; Lu, Darlene ; Mellors, John ; Kuritzkes, Daniel R ; Perelson, Alan S ; Ribeiro, Ruy M ; ACTG A5249s protocol team2015 Nov 28AIDS1829
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202.Grant, Philip M ; Tierney, Camlin ; Budhathoki, Chakra ; Daar, Eric S ; Sax, Paul E ; Collier, Ann C ; Fischl, Margaret A ; Zolopa, Andrew R ; Balamane, Maya ; Katzenstein, David2013 Nov-DecHIV Clin Trials614
Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data.Simpson, Kit N ; Dietz, Birgitta ; Baran, Robert W ; Garren, Kevin W ; Riddler, Sharon A ; Bhor, Menaka ; Haubrich, Richard H2011Cost Eff Resour Alloc9
Educational attainment and response to HAART during initial therapy for HIV-1 infection.Marc, Linda G ; Testa, Marcia A ; Walker, Alexander M ; Robbins, Gregroy K ; Shafer, Robert W ; Anderson, Norman B ; Berkman, Lisa F ; ACTG Data Analysis Concept Sheet Study Team2007 AugJ Psychosom Res263
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention.Podany, Anthony T ; Bao, Yajing ; Swindells, Susan ; Chaisson, Richard E ; Andersen, Janet W ; Mwelase, Thando ; Supparatpinyo, Khuanchai ; Mohapi, Lerato ; Gupta, Amita ; Benson, Constance A ; Kim, Peter ; Fletcher, Courtney V ; AIDS Clinical Trials Group A5279 Study Team2015 Oct 15Clin Infect Dis861
Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants.Bednasz, Cindy J ; Venuto, Charles S ; Ma, Qing ; Daar, Eric S ; Sax, Paul E ; Fischl, Margaret A ; Collier, Ann C ; Smith, Kimberly Y ; Tierney, Camlin ; Yang, Yang ; Wilding, Gregory E ; Morse, Gene D2017 DecTher Drug Monit639
Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts.Ribaudo, Heather J ; Kuritzkes, Daniel R ; Lalama, Christina M ; Schouten, Jeffrey T ; Schackman, Bruce R ; Acosta, Edward P ; Gulick, Roy M2008 Apr 1J Infect Dis7197
The effect of aging on T-regulatory cell frequency in HIV infection.Tenorio, Allan R ; Spritzler, John ; Martinson, Jeffrey ; Gichinga, Caroline N ; Pollard, Richard B ; Lederman, Michael M ; Kalayjian, Robert C ; Landay, Alan L2009 MarClin Immunol3130
The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation.Geng, Elvin H ; Kahn, James S ; Chang, Olivia C ; Hare, C Bradley ; Christopoulos, Katerina A ; Jones, Diane ; Petersen, Maya L ; Deeks, Steven G ; Havlir, Diane V ; Gandhi, Monica2011 NovClin Infect Dis1053
Effect of antiretroviral therapy and hepatitis c co-infection on changes in lipid levels in HIV-Infected patients 48 weeks after initiation of therapy.Stapleton, J T ; Bennett, K ; Bosch, R J ; Polgreen, P M ; Swindells, S2007 Nov-DecHIV Clin Trials68
Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384.Gandhi, Rajesh T ; Spritzler, John ; Chan, Ellen ; Asmuth, David M ; Rodriguez, Benigno ; Merigan, Thomas C ; Hirsch, Martin S ; Shafer, Robert W ; Robbins, Gregory K ; Pollard, Richard B ; ACTG 384 Team2006 Aug 1J Acquir Immune Defic Syndr442
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1.Jacobson, Jeffrey M ; Bosinger, Steven E ; Kang, Minhee ; Belaunzaran-Zamudio, Pablo ; Matining, Roy M ; Wilson, Cara C ; Flexner, Charles ; Clagett, Brian ; Plants, Jill ; Read, Sarah ; Purdue, Lynette ; Myers, Laurie ; Boone, Linda ; Tebas, Pablo ; Kumar, Princy ; Clifford, David ; Douek, Daniel ; Silvestri, Guido ; Landay, Alan L ; Lede2016 JulAIDS Res Hum Retroviruses732
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.Acosta, Edward P ; Kendall, Michelle A ; Gerber, John G ; Alston-Smith, Beverly ; Koletar, Susan L ; Zolopa, Andrew R ; Agarwala, Sangeeta ; Child, Michael ; Bertz, Richard ; Hosey, Lara ; Haas, David W2007 SepAntimicrob Agents Chemother951
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study.Ribaudo, Heather J ; Liu, Huan ; Schwab, Matthias ; Schaeffeler, Elke ; Eichelbaum, Michel ; Motsinger-Reif, Alison A ; Ritchie, Marylyn D ; Zanger, Ulrich M ; Acosta, Edward P ; Morse, Gene D ; Gulick, Roy M ; Robbins, Gregory K ; Clifford, David ; Haas, David W2010 Sep 1J Infect Dis5202
Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.Weinberg, Adriana ; Park, Jeong-Gun ; Bosch, Ronald ; Cho, Alice ; Livingston, Elizabeth ; Aweeka, Fran ; Cramer, Yoninah ; Watts, D Heather ; Luque, Amneris E ; Cohn, Susan E2016 Feb 1J Acquir Immune Defic Syndr271
Effect of early versus deferred antiretroviral therapy for HIV on survival.Kitahata, Mari M ; Gange, Stephen J ; Abraham, Alison G ; Merriman, Barry ; Saag, Michael S ; Justice, Amy C ; Hogg, Robert S ; Deeks, Steven G ; Eron, Joseph J ; Brooks, John T ; Rourke, Sean B ; Gill, M John ; Bosch, Ronald J ; Martin, Jeffrey N ; Klein, Marina B ; Jacobson, Lisa P ; Rodriguez, Benigno ; Sterling, Timothy R ; Kirk, Grego2009 Apr 30N Engl J Med18360
The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection.Chew, Kara W ; Hua, Lei ; Bhattacharya, Debika ; Butt, Adeel A ; Bornfleth, Lorelei ; Chung, Raymond T ; Andersen, Janet W ; Currier, Judith S2014 DecOpen Forum Infect Dis31
Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects.Twigg Iii, Homer L ; Weiden, Michael ; Valentine, Fred ; Schnizlein-Bick, Carol T ; Bassett, Roland ; Zheng, Lu ; Wheat, Joseph ; Day, Richard B ; Rominger, Helen ; Collman, Ronald G ; Fox, Lawrence ; Brizz, Barbara ; Dragavon, Joan ; Coombs, Robert W ; Bucy, R Pat ; AIDS Clinical Trials Group Protocol 723 Team2008 Jan 1J Infect Dis1197
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.Bar, Katharine J ; Sneller, Michael C ; Harrison, Linda J ; Justement, J Shawn ; Overton, Edgar T ; Petrone, Mary E ; Salantes, D Brenda ; Seamon, Catherine A ; Scheinfeld, Benjamin ; Kwan, Richard W ; Learn, Gerald H ; Proschan, Michael A ; Kreider, Edward F ; Blazkova, Jana ; Bardsley, Mark ; Refsland, Eric W ; Messer, Michael ; Clarridg2016 11 24N Engl J Med21375
Effect of HIV-1 infection on human DNA yield from saliva.Basham, Rebecca J ; Richardson, Danielle M ; Sutcliffe, Cara B ; Haas, David W2009 Jul-AugHIV Clin Trials410
Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients.Bakshi, Rahul P ; Hamzeh, Fayez ; Frank, Ian ; Eron, Joseph J ; Bosch, Ronald J ; Rosenkranz, Susan L ; Cramer, Yoninah S ; Ussery, Michael ; Flexner, Charles2007 NovAIDS Res Hum Retroviruses1123
The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine.Eron, Joseph J ; Bosch, Ronald J ; Bettendorf, Daniel ; Petch, Leslie ; Fiscus, Susan ; Frank, Ian ; Adult Clinical Trials Group 307 Protocol Team2007 Jun 1J Acquir Immune Defic Syndr245
Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-experienced HIV-infected Children.Moholisa, Retsilisitsoe R ; Schomaker, Michael ; Kuhn, Louise ; Castel, Sandra ; Wiesner, Lubbe ; Coovadia, Ashraf ; Strehlau, Renate ; Patel, Faeezah ; Pinillos, Francoise ; Abrams, Elaine J ; Maartens, Gary ; McIlleron, Helen2016 DecPediatr Infect Dis J1235
Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patients.Velilla, P A ; Shata, M T ; Lages, C S ; Ying, J ; Fichtenbaum, C J ; Chougnet, C2008 JanAIDS Res Hum Retroviruses124
Effect of low-dose ritonavir on the pharmacokinetics of the CXCR4 antagonist AMD070 in healthy volunteers.Cao, Ying Jun ; Flexner, Charles W ; Dunaway, Shelia ; Park, Jeong-Gun ; Klingman, Karin ; Wiggins, Ilene ; Conley, Jeanne ; Radebaugh, Christine ; Kashuba, Angela D ; MacFarland, Ron ; Becker, Stephen ; Hendrix, Craig W2008 MayAntimicrob Agents Chemother552
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.Gandhi, Rajesh T ; Zheng, Lu ; Bosch, Ronald J ; Chan, Ellen S ; Margolis, David M ; Read, Sarah ; Kallungal, Beatrice ; Palmer, Sarah ; Medvik, Kathy ; Lederman, Michael M ; Alatrakchi, Nadia ; Jacobson, Jeffrey M ; Wiegand, Ann ; Kearney, Mary ; Coffin, John M ; Mellors, John W ; Eron, Joseph J ; AIDS Clinical Trials Group A5244 team2010PLoS Med87
Effect of raltegravir resistance mutations in HIV-1 integrase on viral fitness.Hu, Zixin ; Kuritzkes, Daniel R2010 OctJ Acquir Immune Defic Syndr255
Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis.Hennig, Stefanie ; Naiker, Suhashni ; Reddy, Tarylee ; Egan, Deirdre ; Kellerman, Tracy ; Wiesner, Lubbe ; Owen, Andrew ; McIlleron, Helen ; Pym, Alexander2015 Oct 19Antimicrob Agents Chemother160
Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death.Overton, E T ; Kitch, D ; Benson, C A ; Hunt, P W ; Stein, J H ; Smurzynski, M ; Ribaudo, H J ; Tebas, P2013 MayClin Infect Dis1056
Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients.Clifford, D B ; Smurzynski, M ; Park, L S ; Yeh, T-M ; Zhao, Y ; Blair, L ; Arens, M ; Evans, S R2009 Jul 28Neurology473
Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5Nixon, Daniel E ; Bosch, Ronald J ; Chan, Ellen S ; Funderburg, Nicholas T ; Hodder, Sally ; Lake, Jordan E ; Lederman, Michael M ; Klingman, Karin L ; Aberg, Judith A ; AIDS Clinical Trials Group Study A5275 Team2017 Jan - FebJ Clin Lipidol111
Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort.Smurzynski, Marlene ; Wu, Kunling ; Letendre, Scott ; Robertson, Kevin ; Bosch, Ronald J ; Clifford, David B ; Evans, Scott ; Collier, Ann C ; Taylor, Michael ; Ellis, Ronald2011 Jan 28AIDS325
Effects of HCV treatment on cytokine expression during HCV/HIV coinfection.Blackard, Jason T ; Kang, Minhee ; Sherman, Kenneth E ; Koziel, Margaret James ; Peters, Marion G ; Chung, Raymond T2006 NovJ Interferon Cytokine Res1126
The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era.Gupta, Samir K ; Smurzynski, Marlene ; Franceschini, Nora ; Bosch, Ronald J ; Szczech, Lynda A ; Kalayjian, Robert C ; AIDS Clinical Trials Group Longitudinal Linked Randomized Trials Study Team2009Antivir Ther414
Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.Mulligan, Kathleen ; Yang, Yang ; Wininger, David A ; Koletar, Susan L ; Parker, Robert A ; Alston-Smith, Beverly L ; Schouten, Jeffrey T ; Fielding, Roger A ; Basar, Michael T ; Grinspoon, Steven2007 Jan 2AIDS121
Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients.Bedimo, Roger ; Kang, Minhee ; Tebas, Pablo ; Overton, Edgar T ; Hollabaugh, Kimberly ; McComsey, Grace ; Bhattacharya, Debika ; Evans, Christopher ; Brown, Todd T ; Taiwo, Babafemi2016 AprAIDS Res Hum Retroviruses432
Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384.Dubé, Michael P ; Parker, Robert A ; Mulligan, Kathleen ; Tebas, Pablo ; Robbins, Gregory K ; Roubenoff, Ronenn ; Grinspoon, Steven K2007 Jul 1Clin Infect Dis145
Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.Bhasin, Shalender ; Parker, Robert A ; Sattler, Fred ; Haubrich, Richard ; Alston, Beverly ; Umbleja, Triin ; Shikuma, Cecilia M ; AIDS Clinical Trials Group Protocol A5079 Study Team2007 MarJ Clin Endocrinol Metab392
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.Campbell, Thomas B ; Smeaton, Laura M ; Kumarasamy, N ; Flanigan, Timothy ; Klingman, Karin L ; Firnhaber, Cynthia ; Grinsztejn, Beatriz ; Hosseinipour, Mina C ; Kumwenda, Johnstone ; Lalloo, Umesh ; Riviere, Cynthia ; Sanchez, Jorge ; Melo, Marineide ; Supparatpinyo, Khuanchai ; Tripathy, Srikanth ; Martinez, Ana I ; Nair, Apsara ; Walawa2012PLoS Med89
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.Lennox, Jeffrey L ; Landovitz, Raphael J ; Ribaudo, Heather J ; Ofotokun, Ighovwerha ; Na, Lumine H ; Godfrey, Catherine ; Kuritzkes, Daniel R ; Sagar, Manish ; Brown, Todd T ; Cohn, Susan E ; McComsey, Grace A ; Aweeka, Francesca ; Fichtenbaum, Carl J ; Presti, Rachel M ; Koletar, Susan L ; Haas, David W ; Patterson, Kristine B ; Benson, 2014 Oct 7Ann Intern Med7161
Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).Taiwo, Babafemi ; Zheng, Lu ; Gallien, Sebastien ; Matining, Roy M ; Kuritzkes, Daniel R ; Wilson, Cara C ; Berzins, Baiba I ; Acosta, Edward P ; Bastow, Barbara ; Kim, Peter S ; Eron, Joseph J ; ACTG A5262 Team2011 Nov 13AIDS1725
Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164.Grant, Philip M ; Komarow, Lauren ; Lederman, Michael M ; Pahwa, Savita ; Zolopa, Andrew R ; Andersen, Janet ; Asmuth, David M ; Devaraj, Sridevi ; Pollard, Richard B ; Richterman, Aaron ; Kanthikeel, Sudheesh ; Sereti, Irini2012 Dec 1J Infect Dis11206
Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia.Gallien, Sebastien ; Delaugerre, Constance ; Charreau, Isabelle ; Braun, Joséphine ; Boulet, Thomas ; Barrail-Tran, Aurélie ; de Castro, Nathalie ; Molina, Jean-Michel ; Kuritzkes, Daniel R2011 Mar 13AIDS525
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.Hosseinipour, Mina C ; Bisson, Gregory P ; Miyahara, Sachiko ; Sun, Xin ; Moses, Agnes ; Riviere, Cynthia ; Kirui, Fredrick K ; Badal-Faesen, Sharlaa ; Lagat, David ; Nyirenda, Mulinda ; Naidoo, Kogieleum ; Hakim, James ; Mugyenyi, Peter ; Henostroza, German ; Leger, Paul D ; Lama, Javier R ; Mohapi, Lerato ; Alave, Jorge ; Mave, Vidya ; V2016 Mar 19Lancet10024387
Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.Torriani, Francesca J ; Komarow, Lauren ; Parker, Robert A ; Cotter, Bruno R ; Currier, Judith S ; Dubé, Michael P ; Fichtenbaum, Carl J ; Gerschenson, Mariana ; Mitchell, Carol K C ; Murphy, Robert L ; Squires, Kathleen ; Stein, James H ; ACTG 5152s Study Team2008 Aug 12J Am Coll Cardiol752
Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy.Labo, Nazzarena ; Miley, Wendell ; Benson, Constance A ; Campbell, Thomas B ; Whitby, Denise2015 Jun 19AIDS1029
Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure.Sharkey, Mark ; Babic, Dunja Z ; Greenough, Thomas ; Gulick, Roy ; Kuritzkes, Daniel R ; Stevenson, Mario2011 FebPLoS Pathog27
Equal HIV-1 decay kinetics in HSV-2-infected and HSV-2-uninfected clinical trial participants treated with antiretroviral therapy.Schouten, Jeffrey Thomas ; Schiffer, Joshua T2012 May 1J Acquir Immune Defic Syndr160
European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142.Hulgan, Todd ; Haubrich, Richard ; Riddler, Sharon A ; Tebas, Pablo ; Ritchie, Marylyn D ; McComsey, Grace A ; Haas, David W ; Canter, Jeffrey A2011 Jan 2AIDS125
Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095.Li, Li ; Eron, Joseph J ; Ribaudo, Heather ; Gulick, Roy M ; Johnson, Brent A2012J Am Stat Assoc498107
Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial.Sattler, Fred R ; Rajicic, Natasa ; Mulligan, Kathleen ; Yarasheski, Kevin E ; Koletar, Susan L ; Zolopa, Andrew ; Alston Smith, Beverly ; Zackin, Robert ; Bistrian, Bruce ; ACTG 392 Study Team2008 NovAm J Clin Nutr588
Evaluation of HIV-1 ambiguous nucleotide frequency during antiretroviral treatment interruption.Li, Jonathan Z ; Christensen, Julie A ; Wang, Hongying ; Spritzler, John ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group A5197 Study Team2012 Sep 1J Acquir Immune Defic Syndr161
Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression.Li, Binglan ; Verma, Shefali S ; Veturi, Yogasudha C ; Verma, Anurag ; Bradford, Yuki ; Haas, David W ; Ritchie, Marylyn D2018Pac Symp Biocomput23
Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB.Luetkemeyer, Anne F ; Kendall, Michelle A ; Wu, Xingye ; Lourenço, Maria Cristina ; Jentsch, Ute ; Swindells, Susan ; Qasba, Sarojini S ; Sanchez, Jorge ; Havlir, Diane V ; Grinsztejn, Beatriz ; Sanne, Ian M ; Firnhaber, Cynthia ; Adult AIDS Clinical Trials Group A5255 Study Team2014 AprJ Clin Microbiol452
Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.Luetkemeyer, Anne F ; Firnhaber, Cynthia ; Kendall, Michelle A ; Wu, Xingye ; Mazurek, Gerald H ; Benator, Debra A ; Arduino, Roberto ; Fernandez, Michel ; Guy, Elizabeth ; Johnson, Pamela ; Metchock, Beverly ; Sattler, Fred ; Telzak, Edward ; Wang, Yun F ; Weiner, Marc ; Swindells, Susan ; Sanne, Ian M ; Havlir, Diane V ; Grinsztejn, Beat2016 May 1Clin Infect Dis962
Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.Jacobson, Jeffrey M ; Pat Bucy, R ; Spritzler, John ; Saag, Michael S ; Eron, Joseph J ; Coombs, Robert W ; Wang, Rui ; Fox, Lawrence ; Johnson, Victoria A ; Cu-Uvin, Susan ; Cohn, Susan E ; Mildvan, Donna ; O'Neill, Dorothy ; Janik, Jennifer ; Purdue, Lynette ; O'Connor, Deborah K ; Vita, Christine Di ; Frank, Ian ; National Institute of 2006 Sep 1J Infect Dis5194
Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate.Henrich, Timothy J ; Tsibris, Athe M N ; Lewine, Nicolas R P ; Konstantinidis, Ioannis ; Leopold, Kay E ; Sagar, Manish ; Kuritzkes, Daniel R2010 DecJ Acquir Immune Defic Syndr455
Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors.Manasa, Justen ; Varghese, Vici ; Pond, Sergei L Kosakovsky ; Rhee, Soo-Yon ; Tzou, Philip L ; Fessel, W Jeffrey ; Jang, Karen S ; White, Elizabeth ; Rögnvaldsson, Thorsteinn ; Katzenstein, David A ; Shafer, Robert W2017 Sep 14Sci Rep17
Examining the challenges and solutions to the implementation of trials in resource-limited settings: Limited Resource Trials.Blanchard-Horan, Christina ; Stocker, Vicki ; Moran, Laura ; Ferguson, Elaine Okubo ; Klingman, Karin L ; McMahon, Deborah ; Hitti, Jane2012 Jan 1Appl Clin Trials121
Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies.Harrison, Taylor ; Miyahara, Sachiko ; Lee, Anthony ; Evans, Scott ; Bastow, Barbara ; Simpson, David ; Gilron, Ian ; Dworkin, Robert ; Daar, Eric S ; Wieclaw, Linda ; Clifford, David B ; ACTG A5252 Team2013 JulPain Med714
Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responses.Almeida, Coral-Ann M ; Roberts, Steven G ; Laird, Rebecca ; McKinnon, Elizabeth ; Ahmad, Imran ; Keane, Niamh M ; Chopra, Abha ; Kadie, Carl ; Heckerman, David ; Mallal, Simon ; John, Mina2010 Aug 23Vaccine3728
Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients.Chung, Raymond T ; Umbleja, Triin ; Chen, Jennifer Y ; Andersen, Janet W ; Butt, Adeel A ; Sherman, Kenneth E ; Actg A5178 Study Team2012 Mar-AprHIV Clin Trials213
Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation.Dubé, Michael P ; Komarow, Lauren ; Fichtenbaum, Carl J ; Cadden, Joseph J ; Overton, Edgar T ; Hodis, Howard N ; Currier, Judith S ; Stein, James H ; AIDS Clinical Trials Group A5293 Study Team2015 Sep 1Clin Infect Dis561